COVID-19 pneumonia with ARDS and secondary haemophagocytic lymphohistiocytosis: a case report

Hasan ÖLMEZ; Mustafa TOSUN; Edhem ÜNVER; Nurten ARSLAN IŞIK

doi:https://doi.org/10.18621/eurj.783155

Makale detayları

COVID-19 pneumonia with ARDS and secondary haemophagocytic lymphohistiocytosis: a case report

Yazarlar:

Hasan ÖLMEZ | Mustafa TOSUN | Edhem ÜNVER | Nurten ARSLAN IŞIK

Yayıncı:

Prusa Medical Publishing

Ana Başlıklar:

Hastalıklar

Dergi:

The European Research Journal 2021 Vol.7 Issue 5, pp.533-540

Belge Tipi:

Makale

Yayın Tarihi:

9/2021

Belge Dili:

İngilizce

Document ID (Org No.):

2000661865

Sıklık:

İki Aylık

eISSN:

2149-3189

DOI:

https://doi.org/10.18621/eurj.783155

Özet:

 

Although most people with COVID-19 have mild to moderate symptoms; some people may experience worsened symptoms, such as pneumonia, acute respiratory distress syndrome (ARDS) and and respiratory failure. Here we reported a case of COVID-19 pneumonia with ARDS and secondary haemophagocytic lymphohistiocytosis (sHLH). A 44-year-old man presented to the emergency department with a history of cough, fever, sore throat, and muscle ache. The patient transferred to Chest Diseases Department, with a diagnosis of COVID-19 pneumonia. Oseltamivir, hydroxychloroquine, azithromycin, low molecular weight heparin (LMWH) and favipravir added to the treatment. Tocilizumab started after endotracheal intubation. In general, we saw improvement in respiratory values and vital signs. Administration of LMWH to the patient may have prevented the development of coagulopathy. In conclusion, using HFO system and using low tidal volume according to ARDS net protocol, using optimal PEEP/FiO2 ratio, paying attention to keeping driver pressures low may be beneficial for the clinical improvement of the disease.

Makale detayları

COVID-19 pneumonia with ARDS and secondary haemophagocytic lymphohistiocytosis: a case report

Yazarlar: Hasan ÖLMEZ | Mustafa TOSUN | Edhem ÜNVER | Nurten ARSLAN IŞIK

Yayıncı: Prusa Medical Publishing

Ana Başlıklar: Hastalıklar

Dergi: The European Research Journal 2021 Vol.7 Issue 5, pp.533-540

Belge Tipi: Makale

Yayın Tarihi: 9/2021

Belge Dili: İngilizce

Document ID (Org No.): 2000661865

Sıklık: İki Aylık

eISSN: 2149-3189

DOI: https://doi.org/10.18621/eurj.783155

Sayı

Yazarlar:

Hasan ÖLMEZ | Mustafa TOSUN | Edhem ÜNVER | Nurten ARSLAN IŞIK

Yayıncı:

Prusa Medical Publishing

Ana Başlıklar:

Hastalıklar

Dergi:

The European Research Journal 2021 Vol.7 Issue 5, pp.533-540

Belge Tipi:

Makale

Yayın Tarihi:

9/2021

Belge Dili:

İngilizce

Document ID (Org No.):

2000661865

Sıklık:

İki Aylık

eISSN:

2149-3189

DOI:

https://doi.org/10.18621/eurj.783155